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CASE REPORT
Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis. There are no generally accepted
diagnostic criteria for PsA. Indeed, the diagnosis of this inflammatory arthritis is made by exclusion of other
possible diseases and based upon immunologic, radiologic, and clinical features which are consistent with the
diagnosis. Inflammatory arthritis in a patient with psoriasis can be an important clue for the diagnosis of PsA, but
the possibility for diagnosis of other inflammatory arthritides ever remains. Herein we report a case of a female
patient who was not diagnosed with PsA, but with rheumatoid arthritis, even though she had psoriasis. (Korean J
Intern Med 2010;25:224-226)
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INTRODUCTION
Psoriatic arthritis (PsA) is an inflammatory arthritis
associated with psoriasis. The prevalence of PsA among
patients with psoriasis ranges from 3% to 30% [1-3].
Currently, the diagnosis of PsA is based on clinical,
radiologic, and immunologic features which are consistent
with the diagnosis of psoriatic arthritis, rather than other
inflammatory arthritides, because there are no generally
accepted criteria for the classification of PsA. Sometimes,
it is difficult to differentiate PsA from rheumatoid arthritis
(RA) when the disease is manifested by a polyarticular
pattern and the rheumatoid factor (RF) is positive.
CASE REPORT
A 41-year-old woman was admitted to our hospital
because of multiple joint pains and swelling of 1 month
duration. She had been diagnosed with psoriasis since 10
years of age. Two months previously, her skin lesions were
exacerbated and she had multiple erythematous patches
and pinhead-sized pustules distributed over her entire
body. She was treated with acitretin and narrow-band
ultraviolet B radiation, but her skin lesions did not
improve. After the use of oral prednisolone (30 mg/day),
there was a slight improvement in her skin lesions. The
prednisolone was tapered over 2 weeks. Several days after
cessation of the prednisolone, she began to complain of
pain and swelling involving multiple joints, which led to
her visit to our office for evaluation. On physical examination,
there were multiple tender and swollen joints including
the right shoulder, the elbows, the wrists, the proximal
interphalangeal joints, the knees, and the ankles, but there
was no involvement of the distal interphalangeal (DIP)
joints nor findings of nail dystrophy (Fig. 1). Laboratory
findings revealed a white blood cell count of 11,450 /µL, a
hemoglobin level of 11.9 g/dL, a platelet count of 395,000
/µL, an erythrocyte sedimentation rate of 120 mm/hr, a
C-reactive protein level of 31.7 mg/dL, a RF level of 966
IU/mL, and an anti-cyclic citrullinated peptide antibody
(anti-CCP Ab) titer of 229.3 U/mL. A whole body boneLee KH, et al. Rheumatoid arthritis in a patient with psoriasis     225
scan showed multiple increased uptakes in bilateral 5th
metatarsal phalangeal joints, wrists, and finger joints,
suggesting the presence of inflammatory arthritis, but
plain X-ray studies showed no significant bony
abnormalities, including periostitis and marginal bone
erosion (Fig. 2). On the basis of clinical features such as
symmetric inflammatory polyarthritis of the hand joints
involving more than 3 joints and the presence of RF and
anti-CCP Ab, we assigned the diagnosis of RA with
psoriasis rather than PsA. She had began treatment with
methotrexate (7.5 mg/wk), sulfasalazine (2 g/day),
hydroxychloroquine (200 mg/day), prednisolone (10
mg/day), and meloxicam (15 mg/day). She is now
followed in the regular outpatient department and her
pain and swelling of the joints are improving.  
DISCUSSION
There are currently no diagnostic criteria for PsA; the
diagnosis of PsA is made clinically. Moll and Wright [4]
have described five clinical patterns of joint involvement
in PsA: 1) distal arthritis (involvement of the DIP joints),
2) asymmetric oligoarthritis, 3) symmetric polyarthritis,
4) arthritis mutilans, and 5) spondyloarthropathy. While
distal arthritis and arthritis mutilans are specific for PsA,
polyarthritis is thought to be more frequent in PsA [5].
Sometimes, PsA presenting with a polyarticular pattern is
clinically indistinguishable from RA. Generally, PsA can
be discriminated from RA by physical findings, such as the
presence of DIP joint involvement, an asymmetric pattern
of arthritis, spondyloarthropathy, dactylitis, and nail
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Figure 2. Radiographic assessment. (A) Whole body bone scan shows multifocal increased uptakes on bilateral wrist and finger
joints, suggesting arthritic changes. (B) The plain radiograph of both hands showed no grossly abnormal findings.
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Figure 1. Photographs of the hand and foot. There are multiple erythematous patches suggesting psoriasis on the hand and foot. (A)
Shows swellings on Proximal interphalangeal, Metacarpophalangeal, and wrist joints. (B) Shows swelling of the ankle joints. 226 The Korean Journal of Internal Medicine Vol. 25, No. 2, June 2010
dystrophy. However, the absence of these clinical features
does not exclude PsA as a possible diagnosis. RF exists in
2% to 10% of patients with PsA. Low titers of anti-nuclear
antibodies are also found in nearly one-half of patients
with PsA; clinically significant titers (i.e., ≥ 1 : 80) exist in
14 % of patients with PsA [6]. Anti-CCP Ab, with a high
specificity for RA, are widely used in distinguishing RA
from other disease conditions [7]. However, anti-CCP Ab
are found in 8% to 16% of patients with PsA, especially in
those with erosive and polyarticular disease, and anti-CCP
Ab are also found in those patients with psoriasis alone
[8]. Therefore, the presence of anti-CCP Ab do not exclude
PsA from a possible alternative diagnosis. In this patient,
we made the diagnosis of RA because she had morning
stiffness, arthritis involving more than 3 joints, arthritis
of the hand, RF positivity, and seropositivity for anti-
CCP Ab. However, we could not verfiy that she did not
have PsA because there is no generally agreed upon
diagnostic criteria for PsA.
Several criteria for PsA have been suggested. Recently,
new diagnostic criteria have been suggested by Taylor et
al. [9], the so-called CASPAR (classification criteria for
psoriatic arthritis) criteria, the sensitivity and specificity of
which are 91.4% and 98.7% respectively. The criteria
consist of established inflammatory articular disease with
at least a sum of three points from the following: current
psoriasis (2 points), a history of psoriasis (1 point), a
family history of psoriasis (unless current psoriasis was
present or there was a history of psoriasis; 1 point),
dactylitis (1 point), juxtaarticular new bone formation (1
point), RF negativity (1 point), and nail dystrophy (1
point). In the case of our patient, she had inflammatory
articular disease and psoriasis. Therefore, according to the
CASPAR criteria, she could not be diagnosed with PsA
because she scored 2 points only. 
It is easy to think that a patient with both psoriasis and
inflammatory arthritis may have PsA. However it should
be noted that other forms of arthritis can be present in the
setting of psoriasis and inflammatory arthritis. Assessing
serologic markers, such as RF and anti-CCP Ab, can be of
help in the differential diagnosis, but it should be noted
that the laboratory studies also have limitations, i.e., false
positivity. It is sometimes difficult to diagnose a patient
with PsA due to a lack of internationally accepted criteria.
Newly developed criteria, such as the CASPAR criteria, can
facilitate the diagnosis of PsA. We hope that appropriate
diagnostic criteria will be accepted for the diagnosis of PsA
in the future. 
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